Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
62.92
-1.42 (-2.21%)
At close: Jun 26, 2026, 4:00 PM EDT
62.85
-0.07 (-0.11%)
After-hours: Jun 26, 2026, 7:07 PM EDT
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 370 employees as of December 31, 2025. The number of employees increased by 47 or 14.55% compared to the previous year.
Employees
370
Change (1Y)
47
Growth (1Y)
14.55%
Revenue / Employee
$1,446,159
Profits / Employee
-$130,446
Market Cap
2.71B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Vera Therapeutics | 339 |
| Dyne Therapeutics | 263 |
| Alumis | 227 |
| uniQure | 221 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 154 |
| IDEAYA Biosciences | 145 |
TARS News
- 23 days ago - Tarsus Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Tarsus Pharmaceuticals Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 4 weeks ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Tarsus Pharmaceuticals Transcript: Stifel 2026 Virtual Ophthalmology Forum - Transcripts
- 5 weeks ago - Tarsus Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 6 weeks ago - Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans - GlobeNewsWire
- 6 weeks ago - Tarsus Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Tarsus Pharmaceuticals reports Q1 EPS (16c), consensus (40c) - TheFly